Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Co-Diagnostics, Inc. - Common Stock (NQ: CODX )

0.4776 -0.0224 (-4.48%)
Streaming Delayed Price Updated: 3:58 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Co-Diagnostics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
CODX FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over. 
Via InvestorPlace
CODX NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
CODX INVESTOR NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Co-Diagnostics's Return On Capital Employed Overview
Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) reported Q2 sales of $5.02 million. Earnings fell to a loss of $2.69 million, resulting in a 122.93% decrease from last quarter. 
Via Benzinga
ROSEN, LEADING INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CODX
From The Rosen Law Firm, P.A.
Via Business Wire
NASDAQ:CODX Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Co-Diagnostics, Inc.
San Diego, CA -- (SBWIRE) -- 08/29/2022 -- An investor, who purchased NASDAQ:CODX shares filed a lawsuit against Co-Diagnostics, Inc. over alleged violations of Federal Securities Laws.. 
Via SBWire
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
ROSEN, LEADING INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Co-Diagnostics, Inc. (CODX) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
CODX Stock News: Robbins LLP is Investigating Co-Diagnostics, Inc. (CODX) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
CODX Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Co-Diagnostics, Inc. (CODX)
From Robbins LLP
Via Business Wire
CO-DX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 62 companies set new 52-week lows. 
Via Benzinga
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Co-Diagnostics, Inc. (CODX)
From Robbins LLP
Via Business Wire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CODX
From Rosen Law Firm
Via Business Wire
Mizuho Increases PT On ON Semiconductor, Charter Communications Price Target Cut By 37%
Atlantic Equities lowered the price target on Charter Communications, Inc. (NASDAQ: CHTR) from $755 to $477. Charter Communications shares fell 1.7% to $470.00 in pre-market trading. 
Via Benzinga
This Analyst Boosts Price Target On Dillard's; Also Check Out Some Other Big PT Changes
JP Morgan raised the price target for Dillard's, Inc. (NYSE: DDS) from $210 to $298. Dillard's shares rose 0.9% to $304.42 in pre-market trading. 
Via Benzinga
Illumina, Poshmark, Olo And Some Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS